You are currently viewing a new version of our website. To view the old version click .
Clinics and Practice
  • Clinics and Practice is published by MDPI from Volume 11 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
  • Case Report
  • Open Access

17 October 2012

The Dilemma of Treating Vertebrobasilar Dolichoectasia

,
and
1
Department of Neurology, Mackay Memorial Hospital, Taipei, Taiwan
2
Stroke Center and Department of Neurology, National Cheng Kung University Hospital, Tainan, Taiwan
3
College of Medicine, National Cheng Kung University, Tainan, Taiwan
*
Author to whom correspondence should be addressed.

Abstract

Vertebrobasilar dolichoectasia (VBD) is a common phenomenon among people over 50 years old, and the related clinical expressions are varied. One of our VBD patients presented with brainstem infarction initially, received low molecular weight heparin treatment, and developed rupture of the dolichoectasia segment. Another patient with a similar-sized VBD experienced recurrent brainstem infarction three times over 2 years, despite higher bleeding tendency and long-term antiplatelet treatment. The third patient with a smallersized VBD, had left hemiplegia and received intravenous recombinant tissue plasminogen activator within 3 h, totally recovered with no lesions detected on brain Magnetic Resonance Imaging (MRI). The pathophysiology of VBD is unique, its prevalence and risks of ischemic stroke and intracranial hemorrhage both increase as the degree of arterial dolichoectasia extends, making the strategy of management quite a challenge. The best management of VBD is controlling arterial hypertension and following up with image studies regularly to detect the early extension of VBD degree.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.